Clinical Trials Search at Vanderbilt-Ingram Cancer Center

SPYRAL AFFIRM IDE-G150036

Disease Sites: Not Available

Phase:

Investigator: Fong, Pete

NCTID: NCT05198674

Protocol No: CRE-INT0009

OPTION: Comparison of Anticoagulation with Left Atrial Appendage Closure after AF Ablation

Disease Sites: Not Available

Phase:

Investigator: Kanagasundram, Arvindh

NCTID: NCT03795298

Protocol No: CRE-ARR0004

CHAMPION -AF - WATCHMAN FLX versus NOAC for Embolic Protection in the Management of Patients with Non-Valvular Atrial Fibrillation

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT03795298

Protocol No: CRE-ARR0006

REDUCE LAP II- A study to evaluate the Corvia Medical Inc IASD system II REDUCE Elevated Left Atrial Pressure in Patients with Hear Failure

Disease Sites: Not Available

Phase: II

Investigator: Gupta, Deepak

NCTID:

Protocol No: CRE-CHF0002

ION-682884-CS2 - A Phase 3 Global, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of ION-682884 in Patients with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM)

Disease Sites: Not Available

Phase:

Investigator: Hung, Rebecca

NCTID:

Protocol No: CRE-CHF0006

CSPOT - Conduction System Pacing Optimized Therapy

Disease Sites: Not Available

Phase:

Investigator: Richardson, Travis

NCTID: NCT04905290

Protocol No: CRE-ARR0007

CLASP II TR

Disease Sites: Not Available

Phase: N/A

Investigator: Barker, Colin

NCTID: NCT04097145

Protocol No: VALV0004

REPAIR MR

Disease Sites: Not Available

Phase: N/A

Investigator: Barker, Colin

NCTID: NCT04198870

Protocol No: VALV0007

ADVANTAGE-AF - A Prospective Single Arm Open Label Study of the FARAPULSE Pulsed Field Ablation System in Subjects with Persistent Atrial Fibrillation

Disease Sites: Not Available

Phase:

Investigator: Ellis, Christopher

NCTID: NCT05443594

Protocol No: CRE-ARR0017

A Phase 3, Multi-Center, Randomized, Double-blind Trial to Evaluate the
Efficacy and Safety of Aficamten Compared to Metoprolol in Adults with Symptomatic Obstructive
Hypertrophic Cardiomyopathy” and identified as CY 6032

Disease Sites: Not Available

Phase:

Investigator: Brinkley, Douglas

NCTID: NCT05767346

Protocol No: CRE-CHF0015

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)

Clinical Trials Search CTA Inline Referral Form